ArticleInternational ophthalmology2026
Increased risk of corneal transplant rejection following SARS-CoV-2 infection and vaccination.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo determine the impact of COVID-19 infection and vaccination on risk of corneal transplant rejection.
methodsAll corneal transplants performed in Auckland, New Zealand (NZ), between January 2010 and December 2022 were included. Demographic, clinical, and surgical characteristics were recorded, along with COVID-19 vaccination and infection history. Time to corneal transplant rejection was analysed using Weibull survival regression with clustered standard errors at the graft level to account for repeated events and time-varying covariates.
resultsA total of 1183 corneal transplants were performed in 926 patients, with a median age of 52 years (IQR 32-70); 47.5% were female. The median follow-up was 11.7 years ± 3.8. Within 3 months following COVID-19 vaccination, 1.1% of corneal transplants were rejected; within the same period following COVID-19 infection, 2.3% of transplants rejected. Overall, 277 transplants (23.4%) experienced rejection. On multivariable analysis, COVID-19 vaccination within 3 months was associated with elevated rejection risk (HR 1.834, p = 0.012), while COVID-19 infection within 3 months carried the greatest risk (HR 3.533, p < 0.001). Corneal transplant rejection was associated with significantly worse visual acuity follow-up (rejection median 20/160, no rejection 20/70, p < 0.001).
conclusionsCOVID-19 vaccination and infection were independently associated with an increased likelihood of corneal transplant rejection, with infection conferring the greatest risk. These findings suggest that systemic immune activation induced by SARS-CoV-2 immunisation may disrupt the delicate balance of transplant immunity and tolerance. This is the first large cohort study demonstrating an independent association between recent COVID-19 infection, vaccination, and increased risk of corneal graft rejection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.